Clinical Trials
- Children's Health, Diabetes
CGM Intervention in Teens and Young Adults With Type 1 Diabetes (T1D) (CITY)
- Ages14 years - 24 years
- GenderBoth
- Diabetes
Testing Ultrasound as a new Treatment for Diabetes
- Diabetes
Affordable Housing and Diabetes
- Ages18 years and older
- GenderBoth
- Diabetes
Medtronic CIP335 study for Type I Diabetes
- Diabetes
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus (TN-22)
- Ages3 years and older
- GenderBoth
- Diabetes
Type 2 Diabetes Ultrasound Study
- Ages21 years - 75 years
- GenderBoth
- Diabetes
PREDICT Study : Phenotyping RElatives of persons with Diabetes with CGM and Tests of beta cell function and health (PREDICT): an integrated longitudinal assessment of deep metabolic phenotyping and CGM metrics in youth at risk for T1D
Lifestyle and Glucose Fluctuations (LGF)
- Diabetes
Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes
- Diabetes
Metabolic Changes Induced by a Very Low Carbohydrate Diet in Youth With Type 1 Diabetes
- Ages12 years - 24 years
- GenderBoth